WallStSmart

Abbott Laboratories (ABT)vsInspire Medical Systems Inc (INSP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Abbott Laboratories generates 4831% more annual revenue ($45.13B vs $915.25M). INSP leads profitability with a 14.3% profit margin vs 13.9%. INSP trades at a lower P/E of 9.7x. INSP earns a higher WallStSmart Score of 56/100 (C).

ABT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 4.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.71

INSP

Buy

56

out of 100

Grade: C

Growth: 8.0Profit: 5.5Value: 8.3Quality: 9.0
Piotroski: 5/9Altman Z: 5.32
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ABTSignificantly Overvalued (-28.5%)

Margin of Safety

-28.5%

Fair Value

$70.89

Current Price

$91.07

$20.18 premium

UndervaluedFair: $70.89Overvalued
INSPUndervalued (+85.3%)

Margin of Safety

+85.3%

Fair Value

$462.74

Current Price

$41.19

$421.55 discount

UndervaluedFair: $462.74Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ABT1 strengths · Avg: 9.0/10
Market CapQuality
$151.49B9/10

Large-cap with strong market position

INSP5 strengths · Avg: 10.0/10
P/E RatioValuation
9.7x10/10

Attractively priced relative to earnings

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
308.4%10/10

Earnings expanding 308.4% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.3210/10

Safe zone — low bankruptcy risk

Areas to Watch

ABT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-19.7%2/10

Earnings declined 19.7%

INSP3 concerns · Avg: 2.7/10
Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

Market CapQuality
$1.23B3/10

Smaller company, higher risk/reward

Operating MarginProfitability
-0.6%1/10

Operating margin of -0.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : ABT

The strongest argument for ABT centers on Market Cap. PEG of 1.30 suggests the stock is reasonably priced for its growth.

Bull Case : INSP

The strongest argument for INSP centers on P/E Ratio, Price/Book, EPS Growth.

Bear Case : ABT

The primary concerns for ABT are EPS Growth.

Bear Case : INSP

The primary concerns for INSP are Revenue Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

INSP carries more volatility with a beta of 0.73 — expect wider price swings.

ABT is growing revenue faster at 7.8% — sustainability is the question.

ABT generates stronger free cash flow (916M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ABT scores higher overall (56/100 vs 56/100). INSP offers better value entry with a 85.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Abbott Laboratories

HEALTHCARE · MEDICAL DEVICES · USA

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Visit Website →

Inspire Medical Systems Inc

HEALTHCARE · MEDICAL DEVICES · USA

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.

Want to dig deeper into these stocks?